| Nov 21 |
3 Reasons Growth Investors Will Love Penumbra (PEN)
|
| Nov 20 |
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
|
| Nov 18 |
Inside a $400 billion bet on the brain-computer interface revolution
|
| Nov 17 |
Penumbra, Inc. (PEN): A Bull Case Theory
|
| Nov 7 |
There May Be Some Bright Spots In Penumbra's (NYSE:PEN) Earnings
|
| Nov 6 |
Penumbra reveals positive data for algorithm-assisted thrombectomy tech
|
| Nov 5 |
Here is Why Growth Investors Should Buy Penumbra (PEN) Now
|
| Nov 5 |
Here's Why Penumbra (PEN) is a Strong Momentum Stock
|
| Nov 5 |
New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
|
| Nov 4 |
Implied Volatility Surging for Penumbra (PEN) Stock Options
|
